NCT06088654
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06088654
Title Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innate Pharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Cedars Sinai Los Angeles California 90048 United States Details
Siteman Cancer Center St Louis Missouri 63110 United States Details
Icahn School Of Medicine At Mount Sinai New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Wollongong Private Hospital Wollongong New South Wales 2500 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Peninsula Private Hospital Frankston Victoria 3910 Australia Details
Austin Health Heidelberg Australia Details
Institute Bergonie Bordeaux France Details
Centre Hospitalier Regional Universitaire de Lille Lille France Details
Hospices Civils de Lyon Lyon 69002 France Details
Hôpital de la Coception Marseille 13005 France Details
Centre Hospitalier Universitaire de Nantes Nantes France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field